FIELD: organic chemistry, medicine, endocrinology, pharmacy. SUBSTANCE: invention relates to biaryl compounds or substituted pyridines of the formula (I) where X means N or CR8 where R8 means hydrogen atom, halogen atom, phenyl, alkyl, alkoxy-group, alkoxycarbonyl, carboxy-group, formyl or -NR4R5 where R4 and R5 mean hydrogen atom, alkyl, alkenyl, cycloalkyl, phenyl, naphthyl; R1a and R1в mean trifluoromethyl, alkyl, alkenyl, alkynyl, cycloalkyl, alkanoyl; R2 means alkyl, alkenyl, alkynyl, cycloalkyl; R3 means hydroxy-group, trifluoroacetyl, alkanoyl, alkenyl; Ar means aromatic or heteroaromatic ring, for example, phenyl, naphthyl, pyridyl, furanyl, thiophenyl. Compounds of the formula (I) show antagonistic effect with respect to glucagon receptor and can be used in treatment of glucagons-mediated states, for example, diabetes mellitus. EFFECT: valuable medicinal properties of compounds. 20 cl, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES | 2007 |
|
RU2463292C2 |
AMIDE DERIVATIVES OF PYROSOL | 2015 |
|
RU2658827C2 |
PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR δ ACTIVATING AGENT | 2007 |
|
RU2435764C2 |
SYNTHESIS AND ANTICANCER ACTIVITY OF DERIVATIVES OF ARYL AND HETEROARYL QUINOLINES | 2011 |
|
RU2584688C2 |
2-ARYL-SUBSTITUTED N-ARYLIMIDAZOLINES, SELECTIVE CYCLOOXYGENASE-2 INHIBITORS, METHODS FOR PRODUCTION AND USE THEREOF | 2014 |
|
RU2565667C1 |
SUBSTITUTED 2-AMINOPYRIDINE PROTEIN KINASE INHIBITOR | 2014 |
|
RU2671212C2 |
SULFONYL UREA AND RELATED COMPOUNDS AND USE THEREOF | 2016 |
|
RU2739356C2 |
SUBSTITUTED 4-ARYL-HEXAHYDRO-7H-IMIDAZOLO[1,5-B][1,2]OXAZINE-7-ONES AND METHOD FOR PRODUCTION THEREOF | 2018 |
|
RU2670097C1 |
SULPHONYLUREAS AND RELATED COMPOUNDS AND THEIR USE | 2016 |
|
RU2795512C2 |
4-PHENYL-SUBSTITUTED TETRAHYDROISOQUINOLINES, PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATMENT BASED ON THEREOF | 2001 |
|
RU2301808C2 |
Authors
Dates
2002-12-27—Published
1997-07-29—Filed